Serious Health Conditions Taking Glutathione in high doses can impact your body organs negatively, leading to severe health conditions
As your dose changes through the titration schedule, the optimal concentration may change with it
Combination peptide therapy may be considered for adults who: Are experiencing symptoms of age-related growth hormone decline (typically over 30) Have confirmed low or declining IGF-1 levels on laboratory testing Struggle with poor recovery from exercise or physical stress Experience persistent low energy or disrupted sleep despite healthy habits Notice unfavorable changes in body composition despite consistent diet and activity Want to support healthy aging and longevity through evidence-based interventions Have no contraindications to peptide therapy (active malignancies, certain pituitary conditions) Proper medical evaluation including comprehensive lab work, symptom assessment, and health history review determines whether combination therapy is appropriate and helps establish baseline values for tracking progress

Beyond the obesity data, the Phase 3 study ACHIEVE-1 in people with early type 2 diabetes over 40 weeks documented an HbA1c change of -1.24, -1.47, and -1.48 percentage points at 3, 12, and 36 mg, versus -0.41 percentage points under placebo (Fras et al., NEJM 2025)